Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huiping Shi

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Translational Pediatrics|November 8, 2022
Novel pathogenic variant combination in <i>LPL</i> causing familial chylomicronemia syndrome in an Asian family and experimental validation <i>in vitro</i>: a case reportHuiping Shi, Zhaoyue Wang
Medicine|February 1, 2018
Hemoglobin Hornchurch [β43 (CD2) Glu > Lys; HBB: c.130G > A] in a Chinese boy complicated with thrombocytopenia: A case report and literature reviewHuiping Shi, Zhaoyue Wang
Medicine|February 22, 2018
Atypical microdeletion in 22q11 deletion syndrome reveals new candidate causative genes: A case report and literature reviewHuiping Shi, Zhaoyue Wang
Cells|May 16, 2023
LFA-1 Activation in T-Cell Migration and Immunological Synapse FormationHuiping Shi, Bojing Shao
Journal of Multidisciplinary Healthcare|July 3, 2023
Machine Learning and AI in Cancer Prognosis, Prediction, and Treatment Selection: A Critical ApproachBo Zhang, Huiping Shi, Hongtao Wang
BMC Bioinformatics|July 19, 2022
Identification and validation of a siglec-based and aging-related 9-gene signature for predicting prognosis in acute myeloid leukemia patientsHuiping Shi, Liang Gao, Weili Zhang, et al.
Cancer Medicine|May 6, 2023
Long non-coding RNAs regulate treatment outcome in leukemia: What have we learnt recently?Huiping Shi, Liang Gao, Weili Zhang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 12, 2016
Lapatinib resistance in HER2+ cancers: latest findings and new concepts on molecular mechanismsHuiping Shi, Weili Zhang, Qiaoming Zhi, et al.
Cancer Medicine|December 21, 2023
BLM mutation is associated with increased tumor mutation burden and improved survival after immunotherapy across multiple cancersHuiping Shi, Liang Gao, Hong Yin, et al.
Frontiers in Immunology|August 25, 2022
Current therapeutic strategies and perspectives in refractory ITP: What have we learned recently?Yue Lv, Huiping Shi, Hong Liu, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Translational Pediatrics|November 8, 2022
Novel pathogenic variant combination in <i>LPL</i> causing familial chylomicronemia syndrome in an Asian family and experimental validation <i>in vitro</i>: a case reportHuiping Shi, Zhaoyue Wang
Medicine|February 1, 2018
Hemoglobin Hornchurch [β43 (CD2) Glu > Lys; HBB: c.130G > A] in a Chinese boy complicated with thrombocytopenia: A case report and literature reviewHuiping Shi, Zhaoyue Wang
Medicine|February 22, 2018
Atypical microdeletion in 22q11 deletion syndrome reveals new candidate causative genes: A case report and literature reviewHuiping Shi, Zhaoyue Wang
Cells|May 16, 2023
LFA-1 Activation in T-Cell Migration and Immunological Synapse FormationHuiping Shi, Bojing Shao
Journal of Multidisciplinary Healthcare|July 3, 2023
Machine Learning and AI in Cancer Prognosis, Prediction, and Treatment Selection: A Critical ApproachBo Zhang, Huiping Shi, Hongtao Wang
BMC Bioinformatics|July 19, 2022
Identification and validation of a siglec-based and aging-related 9-gene signature for predicting prognosis in acute myeloid leukemia patientsHuiping Shi, Liang Gao, Weili Zhang, et al.
Cancer Medicine|May 6, 2023
Long non-coding RNAs regulate treatment outcome in leukemia: What have we learnt recently?Huiping Shi, Liang Gao, Weili Zhang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 12, 2016
Lapatinib resistance in HER2+ cancers: latest findings and new concepts on molecular mechanismsHuiping Shi, Weili Zhang, Qiaoming Zhi, et al.
Cancer Medicine|December 21, 2023
BLM mutation is associated with increased tumor mutation burden and improved survival after immunotherapy across multiple cancersHuiping Shi, Liang Gao, Hong Yin, et al.
Frontiers in Immunology|August 25, 2022
Current therapeutic strategies and perspectives in refractory ITP: What have we learned recently?Yue Lv, Huiping Shi, Hong Liu, et al.
Pageof 4